Clinical trial
Treatment of Chronic Cryptosporidiosis in AIDS Patients
NCT00001128 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated
Key facts
| NCT number | NCT00001128 |
|---|---|
| Title | Treatment of Chronic Cryptosporidiosis in AIDS Patients |
| Official title | A Pilot, Proof-of-Concept, Dose-Escalating Trial of Recombinant Human Interleukin-12 (rhIL-12) Versus Placebo Along With Paromomycin and Azithromycin for Chronic Cryptosporidiosis in AIDS |
| Lead sponsor | National Institute of Allergy and Infectious Diseases (NIAID), NIH |
| Collaborators | Genetics Institute Industry |
| Status | Terminated |
| Study type | Interventional |
| Conditions | Cryptosporidiosis, HIV Infections |
| Intervention type | Drug |
| Interventions | Interleukin-12, Paromomycin sulfate, Azithromycin |
| Enrollment | 16 |
| Primary completion | Jun 1, 2005 |
| Completion | Jun 1, 2005 |
| First posted | Aug 31, 2001 |
| Last update posted | Dec 14, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: